HOME PRODUCTS SERVICES COMPANY CONTACT FAQ

Research Dictionary Pharma Mobile

Sign Up FREE or Login

ytterbium-dichlorodimethionine platinum(II)

Subscribe to New Research on ytterbium-dichlorodimethionine platinum(II)

used in the diagnosis of tumors

Also Known As:

169Yb-PtCl2Meth2; Yb-cis-dichlorodimethionine platinum; Yb-dichlorodimethioninoplatin (II)

Networked: 1 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Inorganic Chemicals: 9
- Organometallic Compounds: 19
  - Organoplatinum Compounds
    - ytterbium-dichlorodimethionine platinum(II): 1
Organic Chemicals: 58
- Organometallic Compounds: 19
  - Organoplatinum Compounds
    - ytterbium-dichlorodimethionine platinum(II): 1

Related Diseases

1.

Lymphoma (Lymphomas)

09/01/1995 - "The aim of this study was to assess the diagnostic value of 169Yb-PtCl2Meth2 scintigraphy in patients with malignant lymphomas. "
09/01/1995 - "The results suggest that it is possible to monitor the therapy of malignant lymphoma by means of 169Yb-PtCl2Meth2 scanning."
09/01/1995 - "Scintigraphy with 169Yb-PtCl2Meth2 appears to be a sensitive, non-invasive procedure for the staging of malignant lymphomas. "
09/01/1995 - "169Yb-PtCl2Meth2 scintigraphy was performed in 67 patients with histologically proven malignant lymphoma. "